A study of T Cell-Antigen Coupler (TAC-T cells) for the treatment relapsing/refractory diffuse large B-cell lymphoma (DLBCL).
Phase of Trial: Phase I/II
Latest Information Update: 27 Mar 2018
At a glance
- Drugs Cell therapies (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions
- 27 Mar 2018 New trial record
- 22 Mar 2018 According to Triumvira media release,study is expecting to initiate in Q1 2019 .